NOV Inc. (NOV) earnings date, results and what the price requires
NYSE · SEC CIK 0001021860 · SEC filings checked Oct 17, 2026
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 29, 2026 | Announced; figures arrive with the 10-Q | — | — | Filing |
| Mar 31, 2026 | Apr 15, 2026 | $2.05B | $19.0M | $0.05 | Filing |
| Dec 31, 2025 | Feb 5, 2026 | $2.28B | $-78.0M | $-0.20 | Filing |
| Sep 30, 2025 | Oct 28, 2025 | $2.18B | $42.0M | $0.11 | Filing |
| Jun 30, 2025 | Jul 29, 2025 | $2.19B | $108.0M | $0.29 | Filing |
| Mar 31, 2025 | Apr 29, 2025 | $2.10B | $73.0M | $0.19 | Filing |
| Dec 31, 2024 | Feb 5, 2025 | $2.31B | $160.0M | $0.40 | Filing |
| Sep 30, 2024 | Oct 25, 2024 | $2.19B | $130.0M | $0.33 | Filing |
| Jun 30, 2024 | Jul 26, 2024 | $2.22B | $226.0M | $0.57 | Filing |
What would NOV Inc. have to report for its valuation to change?
At $18.93, with a 9.0% required return and a 18× earnings multiple in 5 years, earnings per share must grow about 45.3% a year, to $1.62. On that path the next quarter needs diluted EPS near $0.42, against $0.29 in the quarter ended Jun 30, 2025.
Compare buying at the last close now with waiting for results: if the report moves the growth the price requires, the entry price you would accept changes with it.
| Result | Original | Yours |
|---|---|---|
| Required EPS growth / year | 45.3% | 45.3% |
| EPS needed in final year | $1.62 | $1.62 |
Changed: nothing yet. Model: EPS × (1+g)^years × final P/E, discounted at the required return, equals today's price. Inputs: SEC diluted EPS and the dated close above.
Prepare for earnings across my investments — $399/month
Keep working models for the companies you follow, compare your expectations with reported results, and review what changes your investment decision. NOV goes in with your buy-or-wait comparison and assumptions preserved.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.